181 related articles for article (PubMed ID: 32367478)
1. Synthesis of the Thomsen-Friedenreich-antigen (TF-antigen) and binding of Galectin-3 to TF-antigen presenting neo-glycoproteins.
Hoffmann M; Hayes MR; Pietruszka J; Elling L
Glycoconj J; 2020 Aug; 37(4):457-470. PubMed ID: 32367478
[TBL] [Abstract][Full Text] [Related]
2. TF-containing MUC1 glycopeptides fail to entice Galectin-1 recognition of tumor-associated Thomsen-Freidenreich (TF) antigen (CD176) in solution.
FitzGerald FG; Rodriguez Benavente MC; Garcia C; Rivero Y; Singh Y; Wang H; Fields GB; Cudic M
Glycoconj J; 2020 Dec; 37(6):657-666. PubMed ID: 33001366
[TBL] [Abstract][Full Text] [Related]
3. Immunoprotective neo-glycoproteins: Chemoenzymatic synthesis of multivalent glycomimetics for inhibition of cancer-related galectin-3.
Heine V; Hovorková M; Vlachová M; Filipová M; Bumba L; Janoušková O; Hubálek M; Cvačka J; Petrásková L; Pelantová H; Křen V; Elling L; Bojarová P
Eur J Med Chem; 2021 Aug; 220():113500. PubMed ID: 33962190
[TBL] [Abstract][Full Text] [Related]
4. Tailored Multivalent Neo-Glycoproteins: Synthesis, Evaluation, and Application of a Library of Galectin-3-Binding Glycan Ligands.
Laaf D; Bojarová P; Pelantová H; Křen V; Elling L
Bioconjug Chem; 2017 Nov; 28(11):2832-2840. PubMed ID: 28976746
[TBL] [Abstract][Full Text] [Related]
5. Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3.
Böcker S; Laaf D; Elling L
Biomolecules; 2015 Jul; 5(3):1671-96. PubMed ID: 26213980
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for distinct binding properties of the human galectins to Thomsen-Friedenreich antigen.
Bian CF; Zhang Y; Sun H; Li DF; Wang DC
PLoS One; 2011; 6(9):e25007. PubMed ID: 21949831
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into the recognition mechanism between an antitumor galectin AAL and the Thomsen-Friedenreich antigen.
Feng L; Sun H; Zhang Y; Li DF; Wang DC
FASEB J; 2010 Oct; 24(10):3861-8. PubMed ID: 20530247
[TBL] [Abstract][Full Text] [Related]
8. A Neoglycoprotein-Immobilized Fluorescent Magnetic Bead Suspension Multiplex Array for Galectin-Binding Studies.
Zhang L; Yu H; Bai Y; Mishra B; Yang X; Wang J; Yu EB; Li R; Chen X
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684775
[TBL] [Abstract][Full Text] [Related]
9. Binding of galectin-1 to breast cancer cells MCF7 induces apoptosis and inhibition of proliferation in vitro in a 2D- and 3D- cell culture model.
Geiger P; Mayer B; Wiest I; Schulze S; Jeschke U; Weissenbacher T
BMC Cancer; 2016 Nov; 16(1):870. PubMed ID: 27825375
[TBL] [Abstract][Full Text] [Related]
10. Thermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides.
Rodriguez MC; Yegorova S; Pitteloud JP; Chavaroche AE; André S; Ardá A; Minond D; Jiménez-Barbero J; Gabius HJ; Cudic M
Biochemistry; 2015 Jul; 54(29):4462-74. PubMed ID: 26129647
[TBL] [Abstract][Full Text] [Related]
11. Molecular Recognition of a Thomsen-Friedenreich Antigen Mimetic Targeting Human Galectin-3.
Santarsia S; Grosso AS; Trovão F; Jiménez-Barbero J; Carvalho AL; Nativi C; Marcelo F
ChemMedChem; 2018 Oct; 13(19):2030-2036. PubMed ID: 30094951
[TBL] [Abstract][Full Text] [Related]
12. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas.
Jeschke U; Mayr D; Schiessl B; Mylonas I; Schulze S; Kuhn C; Friese K; Walzel H
Placenta; 2007; 28(11-12):1165-73. PubMed ID: 17664004
[TBL] [Abstract][Full Text] [Related]
13. Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries.
Peletskaya EN; Glinsky VV; Glinsky GV; Deutscher SL; Quinn TP
J Mol Biol; 1997 Jul; 270(3):374-84. PubMed ID: 9237904
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic Synthesis of N-Acetyllactosamine (LacNAc) Type 1 Oligomers and Characterization as Multivalent Galectin Ligands.
Fischöder T; Laaf D; Dey C; Elling L
Molecules; 2017 Aug; 22(8):. PubMed ID: 28796164
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion.
Yu LG; Andrews N; Zhao Q; McKean D; Williams JF; Connor LJ; Gerasimenko OV; Hilkens J; Hirabayashi J; Kasai K; Rhodes JM
J Biol Chem; 2007 Jan; 282(1):773-81. PubMed ID: 17090543
[TBL] [Abstract][Full Text] [Related]
16. Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody.
Jeschke U; Karsten U; Wiest I; Schulze S; Kuhn C; Friese K; Walzel H
Histochem Cell Biol; 2006 Oct; 126(4):437-44. PubMed ID: 16607538
[TBL] [Abstract][Full Text] [Related]
17. Human galectin-1 and galectin-3 promote
Ayona D; Zarza SM; Landemarre L; Roubinet B; Decloquement P; Raoult D; Fournier PE; Desnues B
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 33573443
[No Abstract] [Full Text] [Related]
18. Biotinylated N-Acetyllactosamine- and N,N-Diacetyllactosamine-Based Oligosaccharides as Novel Ligands for Human Galectin-3.
Böcker S; Elling L
Bioengineering (Basel); 2017 Apr; 4(2):. PubMed ID: 28952509
[TBL] [Abstract][Full Text] [Related]
19. Poly-N-Acetyllactosamine Neo-Glycoproteins as Nanomolar Ligands of Human Galectin-3: Binding Kinetics and Modeling.
Bumba L; Laaf D; Spiwok V; Elling L; Křen V; Bojarová P
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29373511
[TBL] [Abstract][Full Text] [Related]
20. Binding studies on the combining site of a GalNAc alpha 1-->-specific lectin with Thomsen-Friedenreich activity prepared from green marine algae Codium fragile subspecies tomentosoides.
Wu AM; Song SC; Hwang PY; Wu JH; Chang KS
Eur J Biochem; 1995 Oct; 233(1):145-51. PubMed ID: 7588738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
